This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Beta-Alanine
One of maybe three sports supplements with truly bulletproof evidence (creatine, caffeine, beta-alanine).
Aliases (1)
Overview
What is Beta-Alanine?
One of maybe three sports supplements with truly bulletproof evidence (creatine, caffeine, beta-alanine). Loads muscle carnosine ~40-65% over 4-10 weeks at 4-6 g/day, which raises intramuscular H+ buffering across the exact duration window that defines an MMA round (60-240 s of maximal anaerobic effort). Meta-analytic effect ~2-3% on capacity/performance in that domain — modest in absolute terms but reliable and stackable. Side-effect profile is essentially "paresthesia and that's it." For a 20-year-old MMA athlete with a fight-camp on the horizon, this is a default-yes alongside creatine. Load 4.8-6.4 g/day split into 4 × 1.2-1.6 g doses for 8 weeks pre-camp, maintain 2-3 g/day in-camp, drop or hold during weight-cut. Direct rounds-of-MMA fit; verdict locked at STRONG-CANDIDATE / HIGH confidence.
Research Protocols
Disclaimer: These are commonly discussed research protocols and not medical advice.
What to Expect
- Week 1Tolerability and dose-response.
- Week 2-4Early effect window.
- Week 4-8Peak benefit assessment.
- Week 8+Cycle decision point.
Side Effects & Safety
Common (>10%):
- Paresthesia at single doses ≥1.6 g. Harmless, fades 60-90 min. Dose-split or use SR to eliminate.
- Mild GI discomfort at doses >3 g in a single serving — usually resolves with split-dosing.
Uncommon (1-10%):
- Mild flushing in addition to paresthesia in some users — likely a histamine-adjacent response in a small subset.
- Transient sleep disruption if a large dose is taken close to bedtime in a sensitive user — uncommon.
Rare-serious: None established at supplemental doses. Reviewed systematically by ISSN 2015 and by a 2019 meta-analysis on β-alanine risk assessment (PMC6520041). No serum biomarker changes, no organ-specific safety signals at doses up to 6 g/day for 8+ weeks of human trials.
Theoretical concerns (mostly debunked in humans):
- Taurine depletion — β-alanine and taurine share the Tau-T (SLC6A6) and PAT-1 (SLC36A1) transporters. Rodent studies at very high relative doses (≥3% in drinking water) show muscle taurine reductions and downstream effects (one rat study reported retinal nerve fibre layer changes — Murakami 2019 PMID 31473259). In humans at standard supplemental doses, muscle taurine concentration does not measurably decline in the available data. The risk-assessment meta-analysis (2019) concluded no clinical taurine concern. Some cautious practitioners still add 1-3 g/day taurine as a hedge; the evidence base does not require it.
- Histidine depletion — never observed in real human supplementation; histidine intake from a mixed Western diet vastly exceeds the substrate demand of muscle carnosine synthesis. Only a theoretical concern in severe protein restriction.
Watch periods (Dylan-specific):
- First 2 weeks of loading: tingle adaptation. If paresthesia is genuinely intolerable, switch to SR or drop per-dose to 0.8 g × 6/day.
- Weeks 6-8 of loading: confirm the late-round subjective benefit is showing up. If completely absent at 8 weeks of consistent dosing, you're either a non-responder, your training stimulus isn't in the buffering-relevant range, or compliance has been imperfect.
- Weight-cut window: make sure GI tolerance holds at lower calorie intake; sometimes a 1.6 g dose hits harder on an empty stomach.
WADA / drug testing: β-alanine is not on the WADA Prohibited List and is unrestricted in all major combat-sport sanctioning bodies including USADA, UFC's PED program (drug-tested division), ONE Championship's drug-testing program, ABC commissions, and amateur MMA / IBJJF. Safe for any tested athlete.
References
ISSN position stand: Beta-Alanine (Trexler 2015, PMID 26175657)
official ISSN endorsement; 4-6 g/day × ≥2-4 weeks for 1-10 min performance tasks.
View StudyHobson meta-analysis (Hobson 2012, PMID 22270875)
duration-effect curve; +2.85% median improvement, maximal at 60-240 s.
View StudySaunders meta-analysis (Saunders 2017, PMID 27797728)
40 RCTs / 1,461 subjects; SMD 0.18; additive with NaHCO₃.
View StudyHarris 2006 absorption + carnosine synthesis (PMID 16554972)
original kinetics; 3.2 and 6.4 g/day raised muscle carnosine 42-66%.
View StudyHill 2007 cycling capacity (PMID 16868650)
+13% total work at 4 weeks, carnosine +58.8%; +80.1% at 10 weeks.
View StudyKratz 2017 judo Special Judo Fitness Test (PMID 27601217)
6.4 g/day × 4 weeks; +throws per set and total throws; higher peak lactate.
View StudyFernández-Lázaro 2023 combat-sports systematic review (PMC10490143)
7 RCTs; strength, power, and combat-specific gains; mild paresthesia only.
View Study2022 nutritional ergogenic aids in combat sports meta-analysis (PMID 35807770)
boxing, wrestling, judo, jiu-jitsu; +9% throws; NaHCO₃ co-supplementation additive.
View Study2025 Bayesian network meta-analysis on combat-sports supplements (PMID 39747536)
67 RCTs / 1,026 elite combat athletes; β-alanine top tier on lactate and SJFT-index.
View Study2025 dosing-strategy systematic review (PMID 40995761)
fragmented 0.8 g × 5-8/day at 4-6.4 g/day total for 5-8 weeks outperformed single-dose and some SR protocols on strength/power.
View StudySustained-release β-alanine RCT (Maestre-Hernández 2023, PMC10520961)
SR essentially eliminates paresthesia at supratherapeutic 15 g/day; no lab abnormalities.
View StudyLiu 2012 — Mechanisms of itch evoked by β-alanine (PMID 23077038)
MrgprD-mediated paresthesia mechanism.
View StudyShinohara 2004 — MrgprD specifically responsive to β-alanine (PMID 15037633)
receptor identification.
View StudyWhitaker 2022 — β-alanine activation of MRGPRD and NF-κB / IL-6 release (PMC8703779)
in-vitro downstream signaling; clinical significance unknown.
View StudyMurakami 2019 — β-alanine taurine depletion in rats with retinal effects (PMID 31473259)
rodent high-dose; not replicated in humans at supplemental doses.
View StudyDolan 2019 — Systematic risk assessment and meta-analysis on oral β-alanine (PMC6520041)
no clinical safety concerns at supplemental doses; no human muscle taurine depletion.
View StudyCarnosine and beta-alanine supplementation in human medicine — narrative review 2023 (Nutrients)
modern critical assessment beyond sports use.
View StudyWADA Prohibited List 2026
β-alanine not listed; permitted in all WADA-tested sport.
View StudyLatest research
- reviewDosing strategies for β-alanine supplementation in strength and power performance — systematic reviewFragmented dosing (e.g., 0.8 g × 5-8/day) of 4-6.4 g/day for 5-8 weeks most reliably enhanced maximal strength and power outcomes; single large servings and some sustained-release formats failed to improve performance metrics.
- metaAdvantages of dietary supplements for elite combat sports athletes — Bayesian network meta-analysis67 RCTs / 1,026 combat-sport participants. β-alanine ranked top-3 by SUCRA on multiple performance metrics including blood lactate (SUCRA 74.7%) and special-judo-fitness-test index (73.6%), though placebo-comparison significance was inconsistent.
- rctSustained-release β-alanine on labs and paresthesia — RCT in trained menAt 15 g/day for 30 days, SR β-alanine produced paresthesia in 90% but >1/10 VAS intensity in only 1 subject; no adverse lab changes between groups.
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.